Abexinostat (Spanish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Abexinostat" in Spanish language version.

refsWebsite

Global rank Spanish rank

6nih.gov

4^th place

6doi.org

2^nd place

1nist.gov

355^th place

83^rd place

1who.int

195^th place

173^rd place

1cancer.gov

1,684^th place

1,021^st place

1pharmacyclics.com

low place

1web.archive.org

1^st place

cancer.gov

Abexinostat, NCI Cancer Dictionary

doi.org

dx.doi.org

Bhalla, S; Balasubramanian, S; David, K; Sirisawad, M; Buggy, J; Mauro, L; Prachand, S; Miller, R; Gordon, LI; Evens, AM (2009). «PCI-24781 induces caspase and reactive oxygen species-dependent apoptosis through NF-kappaB mechanisms and is synergistic with bortezomib in lymphoma cells». Clinical cancer research : an official journal of the American Association for Cancer Research 15 (10): 3354-65. PMC 2704489. PMID 19417023. doi:10.1158/1078-0432.CCR-08-2365.
Lopez, G; Liu, J; Ren, W; Wei, W; Wang, S; Lahat, G; Zhu, QS; Bornmann, WG; McConkey, DJ; Pollock, RE; Lev, DC (2009). «Combining PCI-24781, a novel histone deacetylase inhibitor, with chemotherapy for the treatment of soft tissue sarcoma». Clinical cancer research : an official journal of the American Association for Cancer Research 15 (10): 3472-83. PMID 19417021. doi:10.1158/1078-0432.CCR-08-2714.
Rivera-Del Valle, N; Gao, S; Miller, CP; Fulbright, J; Gonzales, C; Sirisawad, M; Steggerda, S; Wheler, J; Balasubramanian, S; Chandra, J (2010). «PCI-24781, a Novel Hydroxamic Acid HDAC Inhibitor, Exerts Cytotoxicity and Histone Alterations via Caspase-8 and FADD in Leukemia Cells». International journal of cell biology 2010: 207420. PMC 2817379. PMID 20145726. doi:10.1155/2010/207420.
Yang, C; Choy, E; Hornicek, FJ; Wood, KB; Schwab, JH; Liu, X; Mankin, H; Duan, Z (2011). «Histone deacetylase inhibitor (HDACI) PCI-24781 potentiates cytotoxic effects of doxorubicin in bone sarcoma cells». Cancer chemotherapy and pharmacology 67 (2): 439-46. PMID 20461381. doi:10.1007/s00280-010-1344-7.
Buggy, JJ; Cao, ZA; Bass, KE; Verner, E; Balasubramanian, S; Liu, L; Schultz, BE; Young, PR; Dalrymple, SA (2006). «CRA-024781: A novel synthetic inhibitor of histone deacetylase enzymes with antitumor activity in vitro and in vivo». Molecular cancer therapeutics 5 (5): 1309-17. PMID 16731764. doi:10.1158/1535-7163.MCT-05-0442.
Adimoolam, S; Sirisawad, M; Chen, J; Thiemann, P; Ford, JM; Buggy, JJ (2007). «HDAC inhibitor PCI-24781 decreases RAD51 expression and inhibits homologous recombination». Proceedings of the National Academy of Sciences of the United States of America 104 (49): 19482-7. PMC 2148315. PMID 18042714. doi:10.1073/pnas.0707828104.

nih.gov

ncbi.nlm.nih.gov

Bhalla, S; Balasubramanian, S; David, K; Sirisawad, M; Buggy, J; Mauro, L; Prachand, S; Miller, R; Gordon, LI; Evens, AM (2009). «PCI-24781 induces caspase and reactive oxygen species-dependent apoptosis through NF-kappaB mechanisms and is synergistic with bortezomib in lymphoma cells». Clinical cancer research : an official journal of the American Association for Cancer Research 15 (10): 3354-65. PMC 2704489. PMID 19417023. doi:10.1158/1078-0432.CCR-08-2365.
Lopez, G; Liu, J; Ren, W; Wei, W; Wang, S; Lahat, G; Zhu, QS; Bornmann, WG; McConkey, DJ; Pollock, RE; Lev, DC (2009). «Combining PCI-24781, a novel histone deacetylase inhibitor, with chemotherapy for the treatment of soft tissue sarcoma». Clinical cancer research : an official journal of the American Association for Cancer Research 15 (10): 3472-83. PMID 19417021. doi:10.1158/1078-0432.CCR-08-2714.
Rivera-Del Valle, N; Gao, S; Miller, CP; Fulbright, J; Gonzales, C; Sirisawad, M; Steggerda, S; Wheler, J; Balasubramanian, S; Chandra, J (2010). «PCI-24781, a Novel Hydroxamic Acid HDAC Inhibitor, Exerts Cytotoxicity and Histone Alterations via Caspase-8 and FADD in Leukemia Cells». International journal of cell biology 2010: 207420. PMC 2817379. PMID 20145726. doi:10.1155/2010/207420.
Yang, C; Choy, E; Hornicek, FJ; Wood, KB; Schwab, JH; Liu, X; Mankin, H; Duan, Z (2011). «Histone deacetylase inhibitor (HDACI) PCI-24781 potentiates cytotoxic effects of doxorubicin in bone sarcoma cells». Cancer chemotherapy and pharmacology 67 (2): 439-46. PMID 20461381. doi:10.1007/s00280-010-1344-7.
Buggy, JJ; Cao, ZA; Bass, KE; Verner, E; Balasubramanian, S; Liu, L; Schultz, BE; Young, PR; Dalrymple, SA (2006). «CRA-024781: A novel synthetic inhibitor of histone deacetylase enzymes with antitumor activity in vitro and in vivo». Molecular cancer therapeutics 5 (5): 1309-17. PMID 16731764. doi:10.1158/1535-7163.MCT-05-0442.
Adimoolam, S; Sirisawad, M; Chen, J; Thiemann, P; Ford, JM; Buggy, JJ (2007). «HDAC inhibitor PCI-24781 decreases RAD51 expression and inhibits homologous recombination». Proceedings of the National Academy of Sciences of the United States of America 104 (49): 19482-7. PMC 2148315. PMID 18042714. doi:10.1073/pnas.0707828104.

nist.gov

webbook.nist.gov

Número CAS

pharmacyclics.com

Abexinostat HCl (PCI-24781), PanHDAC-inhibitor Archivado el 27 de octubre de 2013 en Wayback Machine., Pharmacyclics

web.archive.org

Abexinostat HCl (PCI-24781), PanHDAC-inhibitor Archivado el 27 de octubre de 2013 en Wayback Machine., Pharmacyclics

who.int

WHO Drug Information, Vol. 25, No. 2, 2011